3i to acquire Active Pharmaceutical Ingredients for $395m

3i is to back the buyout of Active Pharmaceutical Ingredients, an international developer and supplier of specialist active pharmaceutical ingredients and a division of New York Stock Exchange-listed Alpharma, for around $395m (€267m).

CalPERS begins secondary sell-off

The California Public Employees' Retirement System has sold a portfolio of fund investments to a five-strong secondaries consortium.

Olivant pulls out of Northern Rock

Olivant, the private equity firm run by former Abbey boss Luqman Arnold, has pulled out of the running for Northern Rock.

Anonymous US house invests £50m in Gyro International

An unnamed US private equity investor has injected £50m (€67m) into Gyro International. Electra Quoted and Octopus Private Equity have exited their investments as a result of the deal.

Bank of Scotland backs Verna Group secondary buyout

Bank of Scotland Integrated Finance has backed the secondary management buyout of Verna Group from LGV Capital.

Barclays Private Equity invests in Martek Power

Barclays Private Equity has acquired a majority stake in power converter business Martek Power.